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Isolation and immunological characterization of human gb-
merular basement membrane antigens. About S % of the cases of
human glomerulonephritis are mediated by antiglomerular base-
ment membrane (GBM) antibodies produced by the patient and
capable of reacting with his own GBM antigen(s). To elucidate
the nature of the antigen(s) in human antiGBM nephritis that
reacts with antiGBM antibodies, insoluble human GBM was
rendered soluble by digestion of the basement membrane collagen
with collagenase or by extraction with 3.5 M KBr. Collagenase
digestion and dialysis effectively solubilized over 98% of the
GBM, while KBr extraction resulted in the solubilization of 23%
of the dry membrane. The immunochemical characterization of
the resultant GBM proteins with rabbit antiGBM antiserum
absorbed with human plasma indicated the presence of at least
seven distinct GBM specific antigens. Both collagenase-solubilized
GBM and its KBr extract are antigenically reactive with renal
eluates from patients with antiGBM nephritis as demonstrated
by 1) absorption experiments, 2) double diffusion analysis and
3) a radioimmune assay. Further purification of the nephritogenic
antigen(s) has been achieved by affinity chromatography with
specific rabbit antiGBM antibodies. To obtain such antibodies,
rabbits were immunized with the immunoprecipitate formed
between the KBr extract and antiGBM antibodies eluted from
a nephritic kidney. The rabbit antisera were absorbed with
human serum and then used in affinity chromatography to
isolate the nephritogenic GBM antigens.
Isoleinent et caractérisation immunologique de l'antigêne de
membrane base gbomérulaire humaine. Environ 5 % des glomerulo-
nephrites humaines ont comme médiateurs des anticorps anti
membrane basale glomérulaire (GBM)s produits par le malade
et susceptibles de réagir avec le ou les antigènes de sa GBM.
Pour élucider Ia nature du ou des antigènes qui, dans la néphrite
humaine par antiGBM, réagissent avec les anticorps antiGBM,
de Ia GBM humaine insoluble a été solubilisée par digestion du
collagéne de Ia membrane basale par La collagénase ou l'extrac-
tion au moyen de KBr 3,5 M. La digestion par Ia collagenase et Ia
dialyse ont solubilisé plus de 98% de Ia GBM, cependant que
l'extraction par KBr avait pour résultat la solubilisation de 23%
de la membrane séche. La caractérisation immunochimique de Ia
protdine de la GBM étudiée au moyen d'un antiserum de lapin
antiGBM absorbé sur plasma humain indique Ia presence d'au
moms sept antigenes distincts specifiques GBM. La GBM
solubilisée par le collagenase et l'extrait KBr sont antigénique-
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ment réactifs avec les Cluats rénaux de malades atteints de
néphrites par antiGBM comme cela est montré par I) des
experiences d'absorption, 2) I'analyse par double diffusion et 3)
l'essai radioimmunologique. Une meilleure purification du ou
des antigènes a été réalisée par chromatographie d'affinité avec
des anticorps specifiques antiGBM de lapin. Pour obtenir ces
anticorps ces lapins ont été immunisés au moyen d'immun-
precipités formés avec l'extrait KBr et les anticorps antiGBM
élués a partir d'un rein néphritique. L'antisérum de lapin a été
absorbé par du serum humain puis utilisd en chromatographie
d'affinité pour isoler les antigénes GBM nephritogénes.
It has been demonstrated that about 5 % of the cases of
human glomerulonephritis are mediated by antibodies pro-
duced by the patient and capable of reacting with his own
glomerular basement membrane (GBM) [1]. These anti-
bodies are immunohistochemically identified as uniform
linear deposits of immunoglobulin along the GBM in gb-
meruli of patients with Goodpasture's syndrome and of
some patients with subacute and chronic glomerulonephritis.
AntiGBM antibodies can be obtained for study from sera
or can be eluted from the kidneys of these patients.
The aim of our study was to isbolate from renal GBM the
antigen or antigens that react with antiGBM antibodies
[nephritogenic antigen(s)] in order to develop a quantitative
test for antiGBM antibodies and to gain a better under-
standing of the immunopathogenesis of this form of gb-
merulonephritis.
Studies by Beisswenger and Spiro [2] demonstrated the
presence of significant amounts of hydroxyproline, hydroxy-
lysine and carbohydrate in human GBM, suggesting that
collagen must be one of the components in GBM. However,
these studies also showed that marked differences exist
between the composition of this membrane and some of the
well-characterized vertebrate collagens [3]. Moreover, when
examined by electron microscopy, GBM does not exhibit
the typical asymmetric cross striation pattern of aggregated
collagen molecules to fibrils. Therefore, GBM can be
classified as a specialized form of connective tissue, since
it has no fibrous structure such as, for instance, skin, ten-
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dons, bones or teeth have. GBM, however, is composed of
collagen and additional moieties, which we shall call in the
following text "noncollagenous proteins."
To isolate the nephritogenic antigen(s) from GBM it is
essential to have it in soluble form, since presently available
purification and characterization techniques are only
applicable to material soluble in aqueous solvents.
The present work is concerned with solubilization of
GBM by collagenase digestion, extraction with 3.5 M KBr
and isolation of the antigen(s) that reacts with antiGBM
antibodies. AntiGBM antibodies eluted from the kidneys
of patients with Goodpasture's syndrome are used as a
biological tool for detecting and isolating the specific anti-
gen(s).
Preparation of GBM
Methods
GBM was isolated by the method of Spiro [4] from nor-
mal human kidneys obtained at autopsy. The purity of the
preparation was evaluated by chemical analysis and by
ultrastructural analysis with the electron microscope.
The ultrastructure of the membrane appeared amorphous,
similar to that seen in intact glomeruli. Cell fragments were
not detectable. The average total phosphorus was 0.04 %,
indicating negligible quantities of DNA, RNA and phos-
pholipids.
Fractionation of GBM
Extraction with collagenase (C-S-GBM). Collagenase
(type CLSPA) from Clostridium histolyticum (Worthington
Biochemical Corp., Freehold, New Jersey, U.S.A.) was
further purified by gel exclusion chromatography on Se-
phadex C-IOU (Pharmacia Fine Chemicals, Inc., Piscata-
way, New Jersey, U.S.A.) [5]. The active enzyme fraction
which eluted in the ascending part of the exclusion volume
from the Sephadex column was used. No esterase, amidase,
peptidase or protease activity could be detected, the latter
being tested by using casein as a substrate [6].
GBM was suspended in 0.05 M Tris-HC1 buffer, pH 7.5,
in the presence of 0.01 M CaC12. The sample was incubated
with shaking for 72 hours at 37° C at a hydroxyproline-to-
collagenase weight ratio of 6: 1. The pH was adjusted during
incubation by adding 1 M NaOH. Sodium azide (0.1 %)
was added as a preservative. In order to remove the peptides
from the collagen digest the sample was dialyzed for five
days against ten changes of 0.05 at Tris-HCI buffer, pH 8.0,
containing 0.14 M NaCI (TBS). The retentate was centri-
fuged and the volume reduced by pressure filtration (Ami-
con Corp., Lexington, Mass., U.S.A., type UM-lO). Nitro-
gen and hydroxyproline were determined prior to and also
after incubation with collagenase and dialysis in the super-
natant and the sediment of the retentate. In these analyses
nitrogen present in the collagenase was taken into account.
Extraction with potassium bromide (KBr-E). GBM was
suspended in 3.5 at KBr, 0.02 M Tris-HCI buffer, pH 7.3.
The sample was stirred for 24 hours at 34° C. The residue
was separated by centrifugation at 105,000 xci for two
hours at 4° C and further extracted two to three times. The
combined supernatants were then dialyzed against TBS,
and the volume was reduced by pressure filtration.
Preparation of antisera
Antiserum to GBM (a-GBM). The antiserum to human
GBM was prepared in rabbits by repeated injection of par-
ticulate GBM. The antigen was incorporated into complete
Freund's adjuvant (1.5 parts Arlacel, 8.5 parts Bayol F,
10 parts phosphate-buffered saline (PBS) containing 50 mg
GBM/ml and 4 mg Mycobacterium tuberculosis H37RA/
ml). Initially, animals (2.5 to 3.5 kg New Zealand white
rabbits) were injected with 0.5 ml of the emulsion into each
footpad; subsequent injections of 0.5 ml at four separate
subcutaneous sites were made on days 14 and 28. Animals
were bled and antisera harvested ten days after the last
injection.
For removal of antibodies to plasma proteins I ml of
human plasma, cross-linked with glutaraldehyde as de-
scribed by Avrameas and Ternyck [7], was mixed with I ml
of antiserum by the use of a loose-fitting Potter homogeni-
zer, incubated overnight at 4° C and centrifuged. The ab-
sorbed antiserum was fractionated at 50 % saturation with
ammonium sulfate (pH 6.5), dialyzed against PBS and re-
duced to a final concentration of 10 mg protein/mi.
Antiserum to the nephritogenic antigen (a-NAg). An anti-
serum to the nephritogenic antigen was raised in rabbits
by immunizing them with the immunoprecipitate formed
between the KBr-E and antiGBM antibodies eluted from
the kidney of a patient (J. S.) with Goodpasture's syn-
drome as described by Goudie, Home and Wilkinson [8].
To enhance the reaction, a monoclonal rheumatoid factor
(RF) (1: 16 dilution of a patient's serum) was added in a
ratio of 1: 1. Precipitin lines which formed after three days
were extensively washed with PBS containing sodium azide
(0.1 %) to remove diffusible substances, and then broken up
and emulsified with an equal volume of Freund's complete
adjuvant. The mixture (0.1 ml) was injected into the pop-
liteal lymph nodes. The immunizing dose per rabbit con-
sisted essentially of the material contained within two faint
precipitin arcs. Four weeks later, a secondary injection was
given subcutaneously into the neck at six different sites with
approximately five times the amount of protein used for the
primary injection. Blood samples were obtained ten days
later and the serum was examined by double diffusion
analysis.
Prior to testing, the antisera were absorbed with insolu-
bilized human serum by using glutaraldehyde as cross-link-
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ing agent, fractionated at 50% saturation with ammonium
sulfate, dialyzed and finally concentrated to 10 mg protein!
ml.
Elution of antiGBM antibodies from diseased human kidneys
AntiGBM antibodies were eluted from the kidneys of
patients with Goodpasture's syndrome by the acid-citrate
technique described previously [9].
Immunofluorescent studies
Indirect immunofluorescent detection of antiGBM anti-
bodies. Normal human kidney sections were incubated with
renal eluates and examined by indirect immunofluorescent
microscopy with fluoresceinated [101 rabbit IgG [11] specific
for human IgG as shown by immunoelectrophoresis and
double diffusion. The immunofluorescent techniques used
have been described [12].
Preparation of a C-S-GBM and KBr-E immunoadsorbent.
C-S-GBM and KBr-F immunoadsorbents were prepared
essentially by the method of Cuatrecasas [13]. Protein
(5 mg) in 1 ml of 0.2 M citrate (Na)-HCl buffer, pH 6.5
was added to 1 ml of packed Sepharose 4B (Pharmacia Fine
Chemicals, Inc., Piscataway, New Jersey, U.S.A.) which
had been previously activated with 300 mg of cyanogen
bromide in a total volume of 2 ml. The soluble GBM pro-
teins were linked in nearly quantitative yield to Sepharose.
The immunoadsorbent was washed with PBS and finally
suspended in 5 ml of PBS. A similar control suspension was
prepared with activated Sepharose in PBS.
Absorption experiments. To test the immunological reac-
tivity of C-S-GBM and KBr-E, renal eluates from patients
with Goodpasture's syndrome which had been shown to
fix to GBM were absorbed in separate experiments with the
C-S-GBM or KBr-E immunoadsorbents. Six positive renal
eluates and two control eluates were absorbed with the
KBr-E immunoadsorbent. These absorption experiments
were performed as follows: the immunoadsorbent suspen-
sion (20 tl packed Sepharose containing 25 jig KBr-E pro-
tein) was added to 60 J.d of eluate containing 1.7 to 20.4 jig
IgG, then incubated for half an hour at room temperature
and centrifuged prior to testing. The immunofluorescent
intensity was compared to aliquots after absorption with
equal volumes of activated Sepharose alone. The percentage
of IgG removed from each eluate by the absorption was
quantitated by radial immunodiffusion [14].
Two Goodpasture's eluates were absorbed in similar
experiments using 100 jil of packed Sepharose containing
200 jig C-S-GBM protein and 200 jil of diluted eluate con-
taining 3.4 to 50 jig IgG. To confirm the absorption, the
C-S-GBM immunoadsorbent was washed with PBS,
eluted with 100 jil of 0.03 frI Gly-HC1 buffer, pH 2.4 and
neutralized with 70 jil of 0.1 N NaOH, and the pattern of
immunofluorescence was then compared to equally diluted
aliquots of the same eluate.
Detection of the nephritogenic antigen(s) in soluble extracts
of GBM (C-S-GBM, KBr-E) by a radioimmune assay
The nephritogenic antigen(s) in radioiodinated [15]
C-S-GBM or KBr-E was detected with antiGBM anti-
bodies (renal eluates) by using a secondary precipitating
antibody [16].
Eluted antiGBM antibody (1 to 10 jig) was reacted with
0.1 to 1.5 jig total protein of 1251-labeled C-S-GBM or
KBr-E in a reaction volume of 130 jil for 15 hours at 4° C.
IgG bound 1251-labeled C-S-GBM or KBr-E was then pre-
cipitated with rabbit antihuman IgG. Total precipitation
was assured by the inclusion of a paired label human IgG
in each reaction. The washed precipitate was counted in a
dual channel sodium iodide scintillation counter, and the
percent of 1251-labeled C-S-GBM or KBr-E precipitate was
calculated using the amount of nonspecific precipitate by
the secondary antibody alone as a control. The counts for
1251-labeled C-S-GBM or KBr-E were corrected for preci-
pitability in 10% trichloroacetic acid.
Inhibition of 1251-labeled KBr-E (0.1 jig) binding by
neutral salt soluble rat skin collagen (a gift from Dr. P.
Muller) was compared with that of equal quantities of cold
C-S-GBM.
Isolation of the nephritogenic antigen
The absorbed and fractionated antiserum to the nephri-
togenic antigen (a-NAg) was coupled to a Sepharose matrix
using cyanogen bromide as coupling agent as described by
Cuatrecasas [13].
Protein (100 mg) in 10 ml of 0.2 M (Nat) citrate-HC1
buffer, pH 6.5 was added to 10 ml of packed Sepharose 4B
which had been activated with 3 g of cyanogen bromide,
extensively washed with cold citrate buffer and suspended
in a total volume of 20 ml. The mixture was gently stirred
at 4° C overnight and then washed with a large volume of
water, 5 M NaClO4 and TBS on a Buchner funnel. At each
step the washing was carried out until no further protein
was detectable by absorbence at 280 nm. The amount of
protein recovered was calculated; from this value the per-
centage of protein coupled to the agarose was determined,
and it was routinely 99.6%.
The immunoadsorbent was poured into a glass column
and used to isolate the nephritogenic antigen. In order to
remove nonantigenic material, KBr-E was passed through
the column at a flow rate of 10 mI/hr at room temperature
followed by TBS until no further protein was detected by
absorbence at 280 nm. The absorbed antigen was then
eluted with 5 M NaClO4 [171; the fraction eluted as a sharp
60 Marquardt et al
peak was dialyzed against TBS and was concentrated by
pressure filtration. The column was washed with TBS to be
ready for further use.
Double diffusion experiments
Ouchterlony analyses were performed in 0.6% agarose
according to methods previously described [18].
Immunoelectrophoresis
These procedures were performed essentially by the mi-
cromethod described by Scheidegger [19] on glass slides in
I % ion agar in barbital buffer, pH 8.2, t = 0.04 at protein
concentrations of 5 mg/mI. The conditions for electropho-
resis were 5.5 volts/cm2 for 35 mm at room temperature.
Estimation of serum proteins in C-S-GBM
IgG, 1gM, IgA, fibrin and albumin concentrations in
C-S-GBM were measured by radial imniunodiffusion [14]
by using rabbit antilgG and rabbit antilgM (kindly provided
by Dr. M. B. A. Oldstone), goat antilgA (Hyland Labora-
tories, Inc., Costa Mesa, Calif., U.S.A.), goat antialbumin
(kindly provided by Dr. U. Muller-Eberhard) and rabbit
antifibrin (kindly provided by Dr. T. Edgington).
Quantitative determinations
Total nitrogen analyses of four GBM preparations in
duplicate were carried out by Dr. Paul Maurer. Total nitro-
gen of soluble extracts was measured by an automated
micro-Kjeldahl procedure. A nitrogen content of 16 % was
assumed in converting to protein content. A nitrogen con-
tent of 17.6% was projected for collagen for this purpose
[20].
Hydroxyproline was determined according to Stegemanri
[21] as modified by Woessner [221. A hydroxyproline con-
tent of 13.4% in collagen was assumed for the conversion
to collagen content [23].
Total protein was determined by Lowry's method [24]
using human complement (C3) as a standard.
Fractionation of GBM
Results
Extraction with collagenase. GBM was rendered soluble
by digestion with highly purified collagenase followed by
extensive dialysis and centrifugation. Three fractions were
obtained: 1) a soluble non-dialyzable fraction (C-S-GEM),
Table 1. Distribution of total nitrogen and total hydroxyproline
in fractions prepared from GBM
N
Preparation g/100 g
dry GBM
%
4-Hyp
g/100 g
dry GBM
%
GEM, total 16.0 100.0 8.6 100.0
After collagenase digestion:
1. nondialyzable
(C-S-GBM) 3.7 22.9 0.1 1.3
2. dialyzable 12.1 75.7 8.5 98.7
3. sediment 0.2 1.4 0.0 0.0
2) a dialyzable fraction, and 3) an insoluble fraction of less
than 2% of the total protein. Table 1 gives a quantitative
survey of a typical preparation.
The total GBM and the three fractions were analyzed for
their nitrogen and 4-hydroxyproline content. The total
nitrogen of four different GBM samples determined in
duplicate averaged 16.0% of the dry membrane, and the
total 4-hydroxyproline content was 8.6%. Of the total
nitrogen of the GBM preparation 22.9% was soluble and
was nondialyzable after collagenase digestion. This fraction
contained 1.3% 4-hydroxyproline or less than 3% collagen
peptides. The dialyzable fraction was composed of the
degradation products of collagen, comprising about 99%
of the 4-hydroxyproline content of the dry weight of the
total basement membrane. The insoluble fraction showed
no hydroxyproline, and it accounted for approximately 1 %
of the total nitrogen of the GBM.
in the following paragraph we shall describe the in-
vestigation of the soluble nondialyzable fraction of GBM
(C-S-GBM).
Extraction with potassium bromide. The extraction of
GBM with chaotropic ions like bromide was used as another
means to solubilize human GBM selectively. Table 2 pre-
sents data with regard to the amount of solubilized total
protein obtained during each of the three extraction steps
from one representative preparation of GBM. It is readily
apparent that the yield of soluble material rapidly declined
after the first extract. Therefore, only three extraction pe-
riods were employed because of the minimal amounts of
protein obtained during the fourth extraction period. The
combined extracts represented 22.4 mg protein/100 mg
GBM or 23% of the total protein of the dry membrane which
could be rendered soluble in the presence of 3.5 M KBr.
Table 2. Yield of total protein from GBM during three successive
extracts with 3.5 M KBr, pH 7.3 at 340 C
Extract mg total protein/100 mg dry GBM
1 15.5
2 5.2
3 1.7
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Proteins in the soluble extracts of GBM
Collagenase extract (C-S-GBM). C-S-GBM was first
tested for the presence of plasma proteins by double diffu-
sion analysis in agarose utilizing monospecific antisera
which clearly detected IgG, 1gM, IgA, fibrin or fibrinogen
and albumin. An attempt was made to estimate the extent
of plasma protein contamination by using the radial im-
munodiffusion method. A representative C-S-GBM prepa-
ration used in this study was contaminated by 2.2% albu-
min and 6.8% IgG. The method was too insensitive to
quantitate the values for 1gM, IgA and fibrinogen conta-
minations.
The chemical nature of C-S-GBM proteins proved highly
complex as determined by isoelectric focusing in poly- Fig. 1. Gel diffusion pattern of C-S-GBM and fractions A, B, C
acrylamide gels, SDS acrylamide gel electrophoresis, im- of C-S-GBM after separation on DEAE-cellulose with a-GBM
munoelectrophoresis and double diffusion analysis [25]. antiserum.
For the immunochemical characterization of the noncolla-
genous proteins, a rabbit antiGBM antiserum absorbed
with human plasma was used. This antibody was coupled
to a Sepharose matrix by using cyanogen bromide as the
cross-linking agent. In order to isolate GBM antigens,
C-S-GBM was passed through the antibody agarose col-
umn. Excess nonantigenic material was then removed by
thorough washing with Tris-buffered saline, and the ab-
sorbed antigens were eluted. Ouchterlony analysis indicated
the presence of at least seven distinct GBM antigens when
the antigenic material from the immunoadsorbent column
(C-S-GBM) or fractions of C-S-GBM after separation on
DEAE cellulose (A, B, C) were tested with a rabbit anti-
GBM antiserum absorbed with human plasma (a-GBM)
(Fig. 1).
In addition, fractions A and B of C-S-GBM after sepa-
ration on DEAE cellulose were tested by immunoelectro-
Fig. 2. Immunoelectrophoresis of fractions A and B of C-S-GBMphoresis using the same antiserum. As shown in Fig. 2, after separation on DEAE-cellulose. Antiserum used to develop
GBM antigens migrated in ion agar at pH 8.2 with the precipitin arcs was a-GBM.
mobility of fl-globulins.
Potassium bromide extract (KBr-E). Plasma protein
contaminants in KBr-E were estimated by double diffusion
analysis in agarose, utilizing monospecific antisera which
detected only IgG and albumin but not 1gM, IgA and
fibrin or fibrinogen.
The potassium bromide extract is chemically less complex
than C-S-GBM [26]. When the proteins in KBr-E were
fractionated by SDS electrophoresis in acrylamide, accord-
ing to their molecular size, at least 20 components were
visible with a molecular size range of 28,000 and 94,000
daltons and a considerable amount of protein with a mole-
cular size bigger than 100,000 daltons which did not pene-
trate into a 10% gel.
For the immunochemical characterization of the GBM
proteins in KBr-E a rabbit antiGBM antiserum (a-GBM)
was used which was previously absorbed with human Fig. 3. Double diffusion study showing the heterogeneity of KBr-Eplasma. Gel diffusion analysis revealed the presence of at with a-GBM antiserum and the presence of the nephritogenic
least four different GBM antigens, as shown in Fig. 3. antigen in KBr-E with a-NAg.
62 Marquardt et at
Table 3. Results of in vitro absorption studies performed using renal eluates and soluble antigens derived from GBM
Immunofluorescent Percent
Renal
eluate
Total IgG
pg/test
Immunofluorescent staining
(control)
Immunoadsorbent staining
(immunoadsorbent)
GBM TBM BC
of 100 tg
total IgG
absorbed
••Solubilized
GBM
•Total protein
pg/testGBM TBM BC
D. 0. 1.7 3+ 1+ 1+ KBr-E 25 0 0 0 36
W. A. 2.0 3+ 1 + 3+ KBr-E 25 0 0 0 50
L. P. 2.4 3 + 1 + 1 + KBr-E 25 0 0 3753S. H. 2.0 1+ 1+ — KBr-E 25 0 0 23M.Z. 5.1 2+ 0 0 KBr-E 25 0 0 0
H. M. 9.4 2+ 0 1+ KBr-E 25 0 0 0 19
M. B. 20.4 0 0 0 KBr-E 25 0 0 0
N. K.' 10.0 0 0 0 KBr-E 25 0 0 0 8
J. S. 50.0 3+ 0 0 C-S-GBM 200 0 0 0 NDC
T. T. 3.4 2+ 2+ 0 C-S-GBM 200 0 0 0 ND
a Control eluate: eluate from the kidney of a patient with malignant nephrosclerosis; IgG fixed in a granular, discontinuous pattern
but failed to fix to human kidney sections in vitro.
b Control eluate: eluate from a perfused but not transplanted normal human kidney.
C ND=not determined.
Each eluate was scored (0—4) for its fixation to homologous GBM, Bowman's capsule (BC), tubular basement membrane (TBM).
Detection of the nephritogenic antigen(s) in soluble extracts
of GBM (C-S-GBM, KBr-E)
Absorption experiments. Table 3 illustrates that a C-S-
GBM or KBr-E immunoadsorbent blocks the reaction of
antiGBM antibodies from patients' renal eluates as mea-
sured by indirect immunofluorescent staining of normal
human kidney sections (Fig. 4). The absorbed homologous
antiGBM antibodies could be eluted from the immuno-
adsorbent, and a normal kidney target could be stained
with these eluted antibodies.
By determining the amount of IgG removed from the
eluate by the KBr-E immunoadsorbent, the amount of
specific antibody in the eluate was calculated to be 19 to
53% (Table 3).
Double diffusion experiments. In addition, C-S-GEM and
KBr-E were tested by double diffusion analysis by using an
antiGBM antibody eluted from the kidney of a patient (J. S.)
with Goodpasture's syndrome. A monoclonal RF was in-
cluded to enhance the precipitation (Fig. 5A). Ouchterlony
analysis established that C-S-GBM and KBr-E contained
antigenic material reactive with a patient's renal eluate.
The specificity of the reaction was shown when the renal
eluate alone and a mixture of the same renal eluate plus RF
were tested simultaneously in gel diffusion analysis by using
C-S-GBM as antigen. As shown in Fig. 5B, the added RF
Fig. 4. A. Photomicrograph of
immunofluorescent fixation of
eluted IgG to GBM, Bowman's
capsule and tubular basement
membrane (arrows) of a nor-
mal human kidney section (case
S.H. x250). B. The immuno-
fluorescent fixation of IgG from
the same eluate was blocked by
absorption with KBr-E. Only
autofluorescence remains.
(x 250)
30
0
2000)
10
I-
Renal eluate IgG, tg
Fig. 5. Double diffusion study illustrating the presence of the
nephritogenic antigen in C-S-GBM and KBr-E.
only enhanced the reaction between the antiGBM antibody
and the nephritogenic antigen.
Radioimmune assay. The standard precipitation curve
(Fig. 6) with KBr-E 125J demonstrates that the assay is
capable of detecting the nephritogenic antigen(s) in amounts
> lOng with agreement in duplicate analysis that is usually
within 5%. The relative ability of each eluate to bind the
KBr-E 125J corresponded in general to the amount of active
antibody content as determined by the absorption studies
(Table 3). The limiting factor of this assay may be the bind-
ing affinity of the antiGBM antibodies used. The com-
parison of the precipitation curve at two different concen-
trations each of antigen and renal eluate IgG suggests that
the eluted, acid-treated antiGBM antibody has a rather low
avidity. Insufficient quantities of various renal eluates
tested thus far precluded the construction of complete
binding curves.
All Goodpasture antiGBM eluates tested showed binding
between eluted IgG and '251-labeled KBr-E or C-S-GBM.
The two control eluates (M. B. and N. K.) did not react
with the soluble extracts of GBM.
isolation of the nephritogenic antigen
We attempted to isolate the nephritogenic antigen by
affinity chromatography utilizing a specific antiserum raised
in rabbits by immunizing them with the immunoprecipitate
formed between the KBr-E and antiGBM antibodies eluted
from the kidney of a patient with Goodpasture's syndrome
(a-NAg) [261.
In order to isolate the antigen that induced antiGBM
antibodies in this patient, the KBr-E was passed through
the antibody-agarose column. As depicted in Fig. 7, the
nonantigenic material (Fr. 1) could be easily removed by
washing the column with Tris-buffered saline. The adsorbed
antigen was then eluted with 5 s NaClO4, and the fraction
that eluted as a sharp peak (Fr. 2) was dialyzed and tested
by double diffusion analysis.
Fig. 6. Standard precipitation curves obtained by addition of renal
eluate IgG to a constant amount (0.1 pg and 1 pg protein) of
KBr-E l25J M. B. and N. K. are control eluates free of de-
tectable (indirect immunofluorescence) antiGBM antibodies.
Fig. 8. Double diffusion analysis of Fr. 2 of the immunoadsorbent
column with a renal eluate (J. S.), a-GBM and a-NAg.
For the immunochemical characterization of the nephri-
togenic antigen (Fr. 2) we used first an antiGBM antibody
eluted from the kidney of a patient (J. S.) with Goodpasture's
syndrome; second, the specific rabbit antiGBM anti-
body (a-NAg) which was used for the purification of the
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KBr-E 125J (0.1 ig protein?0 KBr-E 125j(1 .tg protein)/ L.P 20
1IM.BNK' CBNK0••4'
2.5
2.000
1.0
0.5
0 10 20 30 40 50 0 5
Fr.1 1Fr.21
Fraction number
Fig. 7. Chromatographic pattern of KBr-E on a-NAg immuno-
adsorbent. Elution of adsorbed protein was carried out with
5 M NaCIO4.
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antigen; and third, a rabbit antiGBM antiserum absorbed
with normal human plasma (a-GBM). Gel diffusion analysis
revealed that Fr. 2 formed a single line with the renal eluate
but appeared to be contaminated by an additional GBM an-
tigen which was identified by its reaction with a rabbit
antiGBM antiserum, as shown in Fig. 8.
Discussion
In order to isolate the antigen or antigens that induce
antiGBM antibodies in human glomerulonephritis it was
necessary to solubilize normal human GBM. Collagenase
was most effective for the solubilization of the GBM and
was utilized to study its chemical composition. One can
effectively use the restricted specificity of the highly purified
enzyme to obtain the noncollagenous material in its native
form. The GBM was found to be almost completely soluble
once the collagen was digested by collagenase.
The extraction of GBM with potassium bromide selec-
tively solubilized those antigen(s) which specifically reacted
with human antiGBM antibodies. Bromide ions in high
concentrations weaken hydrophobic bonds by making
water more disordered and lipophilic, and dissociate elec-
trostatic linkages releasing 23 % of the total protein of the
dry membrane [to be published].
As has already been reported [27] a number of the non-
collagenous proteins in GBM prove to be plasma proteins
which are trapped so tightly that they cannot be removed by
either sonication or extensive washing of the GBM. How-
ever, the plasma proteins are liberated quantitatively by
collagenase digestion of GBM.
Immunochemical analysis of solubilized basement mem-
brane demonstrated that digestion of GBM with collagenase
or extraction with potassium bromide released a very com-
plex mixture of proteins. At least seven distinct components
were detected by using a rabbit antiGBM antiserum which
had been previously absorbed with human plasma. Studies
of basement membrane proteins by immunoelectrophoresis
suggest heterogeneity of these antigens.
Previous studies on GBM had demonstrated the presence
of two major carbohydrate moieties: a disaccharide con-
sisting of glucose and galactose linked to hydroxylysine
and part of the collagen molecule, and a heteropoly-
saccharide moiety containing mannose, galactose, hexos-
amine, sialic acid and fucose [28]. This carbohydrate
moiety showed variation in its composition, particularly in
its sialic acid content. But differences existed even in the
content of the neutral sugars and hexosamines. Thus, it is
possible that the heterogeneity of solubilized basement
membrane proteins reflects a heterogeneity in their carbo-
hydrate composition or that it may have been induced by
the ultrasonic disruption of glomeruli during the isolation
of GBM.
These studies demonstrated the presence of soluble an-
tigen(s) in extracts of GBM which specifically react with
antiGBM antibodies from patients' renal eluates, as
strengthened by three lines of evidence. First, absorption
experiments performed with C-S-GBM and KBr-E de-
monstrated their capacity to block the fixation of homolo-
gous antiGBM antibodies to normal human kidney sections
as detected by indirect immunofluorescence. The specificity
of antibodies in such eluates has been clearly demonstrated
[9, 29, 30]. Second, double diffusion analysis indicated the
presence of precipitating antiGBM antibodies to soluble
GBM antigens. Third, the capacity of renal eluates to
combine specifically with '251-labeled GBM proteins could
be determined in an antigen binding assay. The specificity
of this assay was shown when two negative control eluates
with comparable amounts of renal eluate IgG, one from a
patient (M. B.) with malignant nephrosclerosis and one from
a normal kidney (N. K.), which had been found not to fix
to normal human kidney sections, did not react with base-
ment membrane antigens.
The nephritogenic antigen(s) is localized in the non-
collagenous portion of the GBM. This could be demonstrat-
ed by an inhibition assay that used, on one hand, comparable
concentrations of a purified rat skin collagen which did not
block the reaction and, on the other, C-S-GBM which
inhibited the interaction between antiGBM antibody and
the specific antigen. The cross-reactivity between rat colla-
gen and GBM collagen has been reported [31].
These observations are inconsistent with a recent report
demonstrating that the nephritogenic antigen resides in
the collagenous part of GBM [32]. These results were based
on absorption studies of a renal eluate with less well char-
acterized GBM fractions and pretreatment of normal
human kidney sections with collagenase followed by use of
indirect immunofluorescent methods.
In our investigations we succeeded in solubilizing, de-
tecting and immunochemically characterizing the GBM
antigen(s) that react with antiGBM antibodies. Fraction-
ation studies are now in progress to isolate and chemically
characterize the specific antigen(s).
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